Intravitreal dexamethasone implant in naïve and previously treated patients with diabetic macular edema: a retrospective study
Author(s) -
Marta Medina-Baena
Publication year - 2020
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2020.10.14
Subject(s) - medicine , diabetic macular edema , dexamethasone , ophthalmology , implant , visual acuity , retrospective cohort study , macular edema , edema , diabetes mellitus , diabetic retinopathy , surgery , endocrinology
To assess the effect of the intravitreal dexamethasone implant (DEX) Ozurdex on the best corrected visual acuity (BCVA) and central retinal thickness (CRT) in patients with diabetic macular edema (DME).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom